Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

World Ovarian Cancer Day | 2019

  • Home Blog World ovarian cancer awareness day

World Ovarian Cancer Day | 2019

May 08, 2019

World Ovarian Cancer Day

Every year on May 8TH women fighting Ovarian Cancer, their families, friends and supporters join hands to raise awareness about Ovarian Cancer. Ovarian cancer has the lowest survival rate of all female cancers. Ovarian Cancer can pose a real tough situation for every woman out there despite their age, and race. GET INVOLVED and do not miss the symptoms.

Go Teal for your Queen.

Downloads

Article in PDF

Recent Articles
  1. Precigen’s PRGN-3006; Yescarta Approved as a First CAR T-cell Therapy for R/R LBCL; Biogen ...
  2. World Malaria Day
  3. VBL Therapeutics’ VB-111 (ofranergene obadenovec); BMS’s mavacamten (Camzyos); Merck’s KEYTRUDA; ...
  4. Frightening Surge in HIV-drug Resistance: The Biggest Challenge Ahead
  5. World Health Day
pharma-news-for-astrazeneca-daiichi-sankyo-basilea-genmab
Notizia - Recent Pharma, Healthcare and Biotech Happenings

AstraZeneca and Daiichi Sankyo’s Enhertu US Approval; Basilea’s ZEVTERA FDA Approval; Genmab’s ProfoundBio Acquisition; Rocket Pharmaceuticals’ RP-L102 EMA Approval; Alexion’s Ultomiris and Soliris AAN 2024 Data

MedTech News for Philips, Boston Scientific, Varian
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Philips Teamed with SyntheticMR; BioPhotas’s Celluma Light Therapy; Boston Scientific’s AGENTTM Drug-Coated Balloon; Varian’s TrueBeam and Edge Radiotherapy Systems; Carthera’s Brain-Blood Barrier Trial; Prototype Device Effectively Treated Multiorgan Failure

Pharma News for AskBio, Merck, SELLAS, RemeGen
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Bayer’s AskBio Initiates Phase II GenePHIT Trial; FDA Approves Merck’s KEYTRUDA Plus Chemoradiotherapy as Treatment for Stage III-IVA Cervical Cancer; FDA Fast Track Designation to SELLAS Life Sciences R/R AML; RemeGen’s RC88; Shorla Oncology Announces FDA Filing Acceptance of New Drug Application for Novel Formulation to Treat Breast and Ovarian Cancer; Tonix Pharma’s TNX-102 SL for Fibromyalgia

GoTeal
Ovarian Cancer
Ovarian Cancer Market
Ovarian Cancer pipeline
Ovarian Cancer Treatment
OvarianCancecrDay
Ovary
ShareThePower
WHO
World Ovarian Cancer Day
WorldOvarianCancerDay
loader